TerminatedNot applicableNCT02105116
AML Therapy With Irradiated Allogeneic Cells
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rutgers, The State University of New Jersey
- Principal Investigator
- Roger Strair, MD, PhD, Ph.DRutgers Cancer Institute of New Jersey
- Intervention
- fludarabine phosphate(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2015
Study locations (1)
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Collaborators
National Cancer Institute (NCI) · Rutgers Cancer Institute of New Jersey
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02105116 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.